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CONSTRUCTING WHITENESS IN HEALTH DISPARITIES RESEARCH
My project is an effort to avert the critical gaze from the racial object to the racial subject; from
the described and imagined, to the describers and imaginers; from the serving to the served.
--- Morrison, 1990:90

INTRODUCTION
Over the past two decades, the body of research documenting and examining racial differences in
health has grown exponentially, from fewer than 20 publications between 1980 and 1989, to more than
130 between 1990 and 1999, and over 700 in the first four years of the new millennium.i This literature
has documented racial disparities in a substantial range of health outcomes, often comparing the health of
one or more racialized groups to the health of “Whites.” In other words, the search for explanations
regarding the cause of racial disparities in health—and indeed, often the definition of racial disparities
itself—is largely framed in terms of explicit or implicit comparisons of racialized groups to the referent
group of White.
Often unspoken and unexamined in these comparisons is the category of Whiteness itself: what it
contains or represents and just what a comparison to Whites tells us. Scholars examining the question of
“Whiteness” have noted that, in contrast to other racial groups, Whiteness has often been defined by what
it is not (Frankenberg, 1993; Fine, 1997)—not marked, not deficit, not raced.
As Toni Morrison suggests in the quotation that serves as the epigraph for this chapter, there is a
long tradition within the United States of constructing Whiteness (the racial subject) against racialized
others (the racial object) and in the process displacing the focus of critical analysis. Here we turn our lens
to the often invisible—or at least underinterrogated—concept of Whiteness within the context of the
literature on racial disparities in health. Specifically, we examine how Whiteness is constructed in the
active literature documenting and interpreting racial disparities in health and the implications of these
constructions for efforts to eradicate inequalities in health. We draw on the concepts of racial formation
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and racial “projects” that emphasize the fluidity, mutability, and historically constructed nature of race, as
well as the social and political processes through which racial categories are created and transformed
(Nagel, 1996; Nobles, 2000; Omi and Winant, 2002; Stevens, 2003; Winant, 1997). In particular, we
apply Winant’s (1997) concept of “racial projects” to examine the construction of Whiteness in ongoing
dialogues about race and racial disparities in health. We consider the ways that varying constructions of
Whiteness enter into, influence, and are influenced by discussions of racial disparities in health, and the
role of those constructions in the reproduction or disruption of racial categories and the inequitable
distribution of resources along racial lines.

RACE AND RACIAL CLASSIFICATION IN HEALTH

The problem of Whiteness and what it means or represents reflects larger dilemmas related to
historical as well as contemporary constructions of race. Questions regarding race as a scientific category
transcend disciplinary boundaries (e.g., Freeman, 1998; American Anthropological Association, 1998;
Duster, 2003b), reflecting the pervasive influence of racialized thinking in scientific endeavors. Although
widely used as analytic categories, racial classification systems have been soundly critiqued as
unscientific, poorly defined, and contingent upon both historical and geographic context. Despite
persistent associations between racial categories and health outcomes, scholars both within and outside of
public health continue to raise critical questions about the use of racial classifications as analytic
categories (Bhopal, 1998; Duster, 2003a; Epstein, Moreno, and Bacchetti, 1997; Farley, Richards, and
Bell, 1995; Hahn, 1999; Hahn and Stroup, 1994; Hahn, Mulinare, and Teutsch, 1992; Hahn, Mendlein,
and Helgerson, 1993; Jackson, 1989; Kaufman, 1999; Mullings, 2004; Nobles, 2000; Witzig, 1996;
Williams, 1997), including questions about their relation to historical processes that created contemporary
inequalities, contemporary definitions, meanings, and interpretations, and their limits in identifying
etiological pathways through which differential health outcomes are produced.
Critics point to the lack of a biologic, genetic, or other “scientific” basis for racial classification
systems and ensuing difficulties creating clear and consistent definitions (Hahn, 1999; Kaufman, 1999;
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Hahn, Mendlein, and Helgerson, 1993). Two illustrative examples involve classifications employed in
census data and birth certificates, both commonly used in health research in the United States. In 1790,
the U.S. Census included three categories: Free Persons (White, and all other free persons except Indians
not taxed); slaves (counted as 3/5 of a person); and Indians living on reservations (not taxed). By 1850,
categories had shifted to more explicitly racial language, denoting simply “white” and “free person of
color.” By 1890, an expanded range of racial categories included “white”; “black” (persons with ¾ or
more Black ancestry); “mulatto” (1/2 Black ancestry); “quadroon” (1/4 Black ancestry); and “octoroon”
(1/8 Black ancestry). By 1910, these categories had contracted to aggregate the previous distinctions in
percent ancestry into just “white,” “black,” and “mulatto” categories. In 1930 and 1940, census takers
were instructed to categorize individuals with White and American Indian ancestry as “Indian,” and those
of African and American Indian ancestry as “African” “unless Indian blood definitely predominates”
(Forbes, 1993:12). In other words, any American Indian ancestry overrode White ancestry to identify
individuals as Indian (not White), while African ancestry overrode American Indian ancestry, except in
cases where African ancestry was small. And, of course, the U.S. racial paradigm of hypodescent means
that a small amount of African ancestry overrides a much larger amount of European ancestry. The 2000
Census reflected renewed expansion of racial options, including five racial categories and two ethnic
categories [Hispanic or Latino; and not Hispanic or Latino]. Respondents were allowed to indicate both
race and ethnicity (OMB, 1978), further expanding the range of ethnic options available. The historically
contingent nature of these racial categories highlights their socially and politically constructed nature and
belies any coherent biological basis or interpretation of contemporary racial groups (Nobles, 2000).
Similarly, racial classification systems used on birth records in the United States reflect changing
gender as well as racial ideologies and practicalities. Prior to 1989, the race of infants indicated on birth
certificates was derived using a complex algorithm. Specifically, infants’ race was coded as paternal race
regardless of maternal race, with two exceptions. In instances where the father’s race was White and the
mother’s race was any other, maternal (rather than paternal) race was used to define the infant’s race. In
contrast, if either parent was Hawaiian, the infant’s race was coded as Hawaiian on the birth certificate.
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In 1989, this system of racial classification was modified, in part due to increasing numbers of children
born for whom the father was not present and therefore father’s race was unknown. Both the previous and
the current system systematically simplify hereditary complexities, although using different racial and
gender heuristics to do so. The examples of the census and birth certificate racial categories highlight the
historical, social, and political nature of racial classification systems and make clear their limitations as
indicators of biological or genetic makeup (see Hahn, Mendlein, and Helgerson, 1993; Cooper and David,
1986; Cooper and Freeman, 1999; Kaufman, 1999; Watson and others, 1993 for more detailed
discussions of the limitations of racial classification systems as indicators of biological or genetic
composition).
These illustrations of the socially, historically, and politically contingent nature of race, combined
with the persistent interpretation of racial categories that emerged out of the specific historical and
political context of the United States as scientifically meaningful, have contributed to lively debate about
how persistent racial differences in health outcomes are best understood and addressed. Even as race is
increasingly recognized as a social construct and racial categories as problematic from an analytic
perspective (Bhopal and Donaldson, 1998; Fullilove, 1998; Williams, 1997; Witzig, 1996), scholars differ
as to how best to address this problem. Some have suggested that “race” should be abandoned entirely in
public health research (Fullilove, 1998) and replaced by explicit attention to the political and social
processes that it represents (e.g., socioeconomic differences, racial discrimination). Others, who would
concur that we must explicitly attend to the political and social processes that create racial disparities in
health, argue that we must continue to use racial and ethnic categories to monitor progress toward
elimination of racial disparities (Baker, 1998; Duster, 2003a; LaVeist, 1994; Mullings, 2004). In other
words, racial categories reflect racialized social systems in the United States, and those systems impact
the health of groups defined by race differently. Attaining equitable health outcomes can only be
assessed if we continue to monitor the health of racially defined groups, recognizing that these differences
are produced through social and political processes.
Even as these discussions about how best to recognize the socially constructed nature of race
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have emerged, interpretations of race as reflecting immutable characteristic of individuals continue, with
racial differences in health viewed as emerging from biologic or genetic differences (Hernstein and
Murray, 1994; Last, 1995; Rushton, 1994; Snyderman and Rothman, 1988). Understanding this struggle
over the very meaning of “race” is central to an analysis of the interplay of race, gender, and class in
health, as well as to an understanding of Whiteness both within health and in United States social and
political systems more broadly.
These debates about the validity and certainly the reliability of the construct of race as an analytic
category have unfolded in the context of a virtual explosion of research drawing attention to racial
differences in health and mortality over the past quarter century. Within this literature, the most common
referent group is “White” (or, more rarely, Caucasian, European, or Western) (Bhopal, 1998). Despite
critical examination of the homogenizing influence of racial or ethnic categories that collapse diverse
national, linguistic, and other identity groups into a single category (e.g., Gimenez, 1989; Williams,
Lavizzo-Mourey, and Warren, 1994) and a trend toward increasing complexity of comparisons within
various racialized groups (e.g., disaggregating analyses of Blacks into African Americans and AfroCaribbeans; disaggregating “Latinos” into Cuban, Puerto Rican, and Mexican American), there has been
relatively little critique of the aggregation of multiple groups into the “White” racial category (Bhopal,
1998). Furthermore, there has been relatively little explicit examination in the public health literature of
how some groups come to be defined as White and the subsequent implications for health. How is it that
the category of White or Whiteness is both pervasive as a comparison or referent group in the literature on
racial disparities in health and at the same time its composition and the meaning or interpretation of
comparisons to “Whites” remains largely uninterrogated? And perhaps more importantly, what are the
implications of this invisibility for understanding and addressing the inequalities in health with which this
literature is concerned?
To begin to examine this question, we borrow the concept of “racial projects.” This concept
emerged in an attempt to capture the active and dynamic efforts of social groups to organize the
distribution of resources along racial lines (Omi and Winant, 2002). Conceptualizing Whiteness, like
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other racial categories, as socially constructed allows Whiteness to be examined as dynamic, as actively
created and maintained, rather than as static, given, or immutable. Thought of in this way, Whiteness is
not genetically derived or granted but is accomplished through the active efforts of human beings who
construct and maintain social boundaries—for example, defining who is White and who is not (see Buck,
2001; Daniels, 1997; Ignatiev, 1995). Creating and maintaining Whiteness as a bounded category that is
largely not visible or marked, and yet manages to retain privilege, is neither a modest nor a simple
venture. A defining feature of Whiteness, then, is the absence or unmarked invisibility of “White” as a
racial category. As many scholars have noted, this invisible and absent quality of Whiteness is itself a
mechanism of privilege (Allen, 1993; Dyer, 1998; Feagin and Vera, 1994; Fine and others, 1997;
Frankenberg, 1993; Ignatiev, 1995; Kincheloe and others, 1998; McIntosh, 1988; Roediger, 1991; 1998),
deflecting attention from Whiteness while simultaneously playing a role in the racialization of those
groups that are defined as not “White.”
Winant suggests that “the problem of the meaning of whiteness appears as a direct consequence
of the movement challenge posed in the 1960s to white supremacy” (Winant, 1997:48-49). As civil rights
movements disrupted previously homogeneous notions of Whiteness, Whites and Whiteness were no
longer exempt from the complex racialization processes that are the hallmark of U.S. history (Winant,
1997:48). Rather, Whiteness has become a more contested and visibly negotiated racial category. The
disruption of the homogeneity of Whiteness brought about by the Civil Rights Movement opened up both
the possibility of an interrogation of White privilege, as well as challenges to civil rights legislation such
as affirmative action through newly galvanized Whites who envisioned themselves as under attack. A
series of recent scholarly works has examined in detail the intersections of race and gender, and in some
cases class and religion, in negotiations that define who is White and who is not, as well as the meaning
of inclusion in various racial categories (e.g., Buck, 2001; Daniels, 1997; Chehade, 2001; Majaj, 2000;
Ferber, 2004). The concept of “Whiteness projects” encourages explicit analyses of active efforts to
negotiate conceptualizations of Whiteness that, in turn, may serve to reproduce or to disrupt racial
inequalities.

7

Winant has sketched several useful typologies for understanding contemporary “white racial
projects”: far right, new right, neoconservative, neoliberal, and new abolitionist (1997). He describes the
Whiteness project of the far right as putting forward biological notions of race as part of a racialized
ideology that views racial differences (racial hierarchies) as immutable and inherent, grounded in genetic
or biological difference. Effectively, this conservative racial project seeks to maintain White privilege
through the argument that Whites are genetically or biologically distinct from and superior to other racial
groups.
Winant describes new right racial projects as differing from those of the far right in their
acceptance of participation by members of non-White racial groups, provided that such participation “is
pursued on a ‘color-blind’ basis and adheres to the rest of the authoritarian, nationalist program” (Winant,
1997:44; see also Mullings, 2005). Despite the appearance of inclusiveness of non-White racial groups,
new right racial projects emphasize the maintenance of White racial privilege through cultural
representations of race that play on racial fears and exacerbate divisions among racial groups—for
example, through the 1988 Willie Horton campaign ads employed by George Bush (Winant, 1994:44). A
more recent example comes from Wilton’s (2002) case study of community opposition to the placement
of “special needs” housing in a San Pedro, California, neighborhood. Wilton demonstrates the ways
opponents to the housing project galvanized a NIMBY campaign that deployed a romanticized, European,
and “Whitened” construction of community which marked “special needs” as outsiders, unwelcome and
unwanted in the community. Wilton’s case study provides an example of the ways in which the new right
racial project of Whiteness emphasizes the maintenance of White racial privilege through cultural
representations of race that play on racial fears and exacerbate divisions among racial groups.
Neoconservative Whiteness is similarly rooted in the politics of the right but seeks to preserve
White advantage through denial of racial difference (1997). Such efforts simultaneously valorize
universalism and individualism, and in so doing they seek to obscure or deny differences that may emerge
from social inequalities. For example, in The End of Racism (1995), D’Souza writes that “racism can be
overcome” by “revising our most basic assumptions about race,” including the notion that “Affirmative
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Action is a policy that assures equal opportunity for disadvantaged African Americans and other
minorities” (1995:2-3). D’Souza and other neoconservatives’ opposition to affirmative action policies
simultaneously appeals to universalism (job or academic performance standards) and individualism
(achievement in meeting those standards). Thus, for neoconservatives, “the end of racism” comes with
renewed focus on universal standards and individual achievement without regard to race. Yet the focus
on universal, race-blind standards within a context in which race still matters (that is, in which Whites are
more likely to have access to the kinds of material and social resources that enable them to achieve those
standards) is a strategy that reinforces and privileges Whiteness. Advocates are actively working to make
this “colorblind” racial project the underpinning of contemporary legal theory and social practices
(Mullings, 2005).
In contrast to these projects, neoliberal Whiteness “seeks to limit white advantage through denial
of racial difference” (Winant, 1997:45). Winant describes neoliberal Whiteness projects as encompassing
social democratic political perspectives that focus on social structure, as opposed to the cultural
representations of race that are employed in the various right-wing racial projects. Within this Whiteness
project, inherent racial differences are negated, and any systematic racial inequality is attributed to
structural, often economically rooted, phenomena. Neoliberal Whiteness maintains that if structural
disadvantages that disproportionately affect Black, Hispanic, and Native American groups were
equalized, then racial differences would disappear.
The final category in Winant’s typology is new abolitionist racial projects. New abolitionist
projects emphasize the historical development of Whiteness and White privilege as central to the
emergence of U.S. capitalism. These studies focus attention on the relations between historical
formations of race and class in the U.S. and promote the deconstruction or repudiation of White racial
privilege. Here we employ Winant’s notions of various racial projects as a way of continuing the
disruption of homogenous Whiteness as it is constructed in health disparities research. To do this, we
examine the constructions of Whiteness that emerge within the context of two literatures in public health:
broadly, the literature on racial disparities in health that focuses on social structural explanations for those
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differences, and discussions of genetic explanations for racial health disparities that have emerged in the
wake of the Human Genome Project.

CONSTRUCTING WHITENESS IN THE CONTEXT OF RACIAL DISPARITIES IN HEALTH

The literature on racial disparities in health by definition involves comparisons across groups
defined by some racial classification system. Perhaps the most common of these comparisons take the
form of the following general proposition: [Black/Hispanic/Native American] [children or adults] have
higher rates of [the condition, disease, or “disability” under investigation] than Whites, primarily
because of [explanatory variable].
This proposition constructs Whiteness in two ways. First, it establishes a comparison between
Whites as a referent group and some “other” group whose health is evaluated in comparison to that of
Whites. In an ideal world, such comparisons may demonstrate arenas in which health outcomes do not
differ by race, challenging ideas of racial group difference. If, however, funders are less likely to support
research in areas in which substantial racial differences are not apparent, or if publishers are less likely to
publish articles that find no statistically significant differences (see Phillips, 2000; Scargle, 2000; Stern,
1997 for discussions of publication bias), the literature will reinforce racial health differences while
minimizing similarities (Gould, 1996; Lewontin, Rose, and Kamin, 1984, Stevens, 2003, Tucker, 1996).
Equally important, however, are the theoretical or conceptual frameworks that underlie questions
about racial disparities. Whether such theoretical frameworks are implicit or explicit, they guide the way
that research questions are framed, as well as the interpretation of results. We have already noted the
absence of a “scientific” foundation for racial categories or even a clear and shared definition of what race
is across and, in some cases, within disciplinary boundaries. Precisely because of the socially constructed
and situated nature of racial constructs, comparisons of racial groups “leave room for multiple
interpretations, including biologic or cultural notions of race as an essential or unchanging constituent of a
person” (Muntaner 1999:122). In other words, the use of racial categories and comparisons with no
consistent foundation for theorizing, understanding, or interpreting observed racial differences (or their
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absence) in health outcomes provides space for a wide range of potential explanations. Each of these
“explanations” implicitly or explicitly constructs both race and Whiteness.
For example, within the literature on racial disparities in cardiovascular disease, comparisons of
Black or Latino/a to White Americans show disparities not only in cardiovascular mortality rates (Cooper
and others, 2000; Wong and others, 2002) but also in multiple risk factors, including high blood pressure
(Cooper and Rotimi, 1997; National Heart Lung and Blood Institute, 2004; Crespo, Loria, and Burt
1996), obesity (James, 1999; Kumanyika, 2001), physical activity (Brownson and others, 2001; Crespo
and others, 1996), and intake of micronutrients and macronutrients associated with cardiovascular risk (Li
and others, 2000). In the absence of an explicitly social theory of race, analyses explaining racial
disparities in cardiovascular disease in terms of biological, “lifestyle,” or “cultural” factors can reify racial
differences and obscure connections to socially structured inequalities. In other words, explaining racial
differences in health in terms of individual biology, genes, or behavior can locate health problems in the
bodies of those most negatively affected by social inequalities. Such explanations fail to make explicit
connections to histories of racism and the struggles against oppression by subordinated groups (BonillaSilva, 2003; Mullings, 2005). In the process, they also take out of the equation—and thus make
invisible—the processes through which Whites maintain positions of relative advantage or privilege
within racial hierarchies. In this sense, such explanations are consistent with the “colorblind” strategies
of neoconservative and neoliberal Whiteness projects described above, in that they explain racial
disparities in health in nonracial terms. The example of cardiovascular disease is one to which we will
return in a moment. First, we want to place this discussion within an historical context.
The failure to make explicit connections between biologic and behavioral factors and race as a
socially constructed system of inequality can also reinforce racial inequalities by playing on racial fears to
exacerbate divisions between groups. An historic example of this is offered by Shah (2001), who
describes the explicit construction of Chinese immigrants living in cramped, substandard housing in San
Francisco. The communicable diseases that were, not surprisingly, common under these conditions were
constructed as a “pestilence” that posed a “danger to the white public” (Shah, 2001:251). Here the
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disproportionate occurrence of communicable diseases among Chinese immigrants led to constructions
that associated disease with the Chinese immigrants themselves rather than with their relative
disadvantage within a racial system, which led to their disproportionate residence in substandard housing.
Even more extreme is the construction of “Negro diseases” such as drapetomania (running away from
enslavement), which defined resistance to slavery as a mental illness (Williams and Harris-Reid, 1999).
Samuel A. Cartwright, M.D., writing on this topic in the 1850s, said, “With the advantage of proper
medical advice, strictly followed, this troublesome practice that many Negroes have of running away can
be almost entirely prevented.” The recommended treatment was whipping, as well as keeping slaves in a
submissive state and treating them like children, with “care, kindness, attention to humanity to prevent
and cure them from running away” (Cartwright, 1981:71; Jackson, 2002; Wren, 1985). Defining
individual responses to enslavement as a mental illness requiring treatment provided a justification for
continued enslavement, with treatment of the medical condition the responsibility of the slave owner
(Szasz, 1971). Simultaneously, locating the “problem” within the bodies and minds of slaves shifted the
lens away from the structured economic system of slavery and the White slaveholders whom it benefited.
More recent examples can be found in the literature on HIV/AIDS, in which the identification of
HIV/AIDS among Haitians and gay men contributed to stigmatization of affected communities and
impeded effective response (Altman, 1986; Brandt, 1987; Cohen, 1996; Sontag, 1989). In each of these
examples, the identification of a particular group most negatively affected by a health or social condition,
combined with cultural representations that play on racial fears and stereotypes, serves to define particular
health concerns within those groups most harmed, contributes to their stigmatization, and obscures White
privilege in a manner that is consistent with Winant’s typology of new right Whiteness projects.
Examples such as these demonstrate the processes through which the causes of racial disparities
in health can be located within those groups most visibly affected, rather than in the social relations that
systematically advantage Whites in relation to other racial groups. What remains invisible is Whiteness
itself, as well as its role in the process of creating and sustaining racial disparities in health by
contributing to unequal access to the resources necessary to maintain health. The failure to explicitly
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conceptualize race as a set of social relations leaves descriptions of racial differences in biological or
behavioral factors associated with differential health outcomes open to interpretations as produced
through biological, genetic, or culturally patterned lifestyle differences. In other words, they “explain
racial inequality as the outcome of nonracial dynamics” (Bonilla-Silva, 2003:2), a hallmark of “colorblind
racism.” Such studies can be interpreted in ways that foster neoliberal, neoconservative, or new right
Whiteness projects.
In an effort to move toward a more explicit analysis that links racial disparities in health to social
contextual factors, a literature on social disparities in health has emerged. This literature attempts to
address the discrepant “life-chances” between poor or working-class and middle-class people and
between Whites and Blacks, Hispanics, or other racialized groups. This body of research attempts to
explain racial and class differences in health outcomes through the identification of unequal exposures to
social conditions that influence health—for example, access to employment opportunities, exposure to
unfair treatment, or exposure to noxious environments.
To return to our earlier example of racial differences in cardiovascular disease, research framed in
terms of social determinants of health might attempt to explicitly link racial disparities in cardiovascular
disease to differentials in access to the resources or environments necessary to maintain health. Studies in
this vein examine, for example, racial or socioeconomic variations in access to healthy and affordable
fruits and vegetables and their implications for dietary practices (Cheadle and others, 1991; Morland and
others, 2002; Nestle and Jacobson, 2000; Swinburn, Egger, and Raza, 1999; Travers, 1996; Zenk and
others, 2005), access to educational and employment opportunities and their implications for
socioeconomic status (Massey and Denton, 1993; Orfield, 1993; 2001; Wacquant and Wilson, 1989), the
location of health care providers and pharmacies and their implications for access to health care
(McLafferty, 1982; Whiteis, 1992), and neighborhood concentrations of poverty and wealth and
implications for cardiovascular risks (Diez-Roux and others, 2001; Kaufman, Cooper, and McGee, 1997).
This literature reflects a move toward a more explicit theoretical conceptualization of racial disparities in
health as resulting from differential access to the resources necessary to maintain health (e.g., education,
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income, access to nutritious foods), which, in turn, influence health-related behaviors and biological
processes associated with cardiovascular disease.
How is Whiteness constructed in this literature? Explanations of racial disparities in health that
focus attention on differential access to resources to promote health (e.g., grocery stores) and differential
exposure to environments that are not conducive to health (e.g., restricted employment opportunities) shift
the explanatory lens from the biology and the behaviors of racialized groups to the contexts within which
people reside. This explanatory shift, depending on the theoretical framework and the explanation for
why there is differential distribution of resources conducive to health, may help disrupt racial categories.
Specifically, these analyses test the extent to which racial differences in health emerge from
differences in social environments rather than from differences in inherent characteristics of racial groups.
They seek to document the contributions of differential access to health-promoting resources and
differential exposure to health risks. They essentially suggest that there are not inherent differences
between racial groups but that differences in health emerge through differences in the social determinants
of health. Extending the argument that race would not matter if exposures to “x” were more equitably
distributed contributes to understanding how social conditions contribute to or create racial differences in
health. However, without an explicit analysis of how risks come to be distributed differentially, such
analyses stop short of making the theoretical or empirical link to the processes that create these unequal
distributions of resources and risks. In other words, they fail to specifically theorize the ways that racial
categories and racialized processes contribute to the accrual of advantage by Whites and the extent to
which those benefits accrue at the expense of non-White people’s health. This leaves Whiteness, and
specifically the way Whiteness is protective of health, unmarked, invisible, and unnoticed. Given that the
research is ostensibly addressing the issue of “race,” and indeed disparities in health, the invisibility of
Whiteness in this context becomes all the more difficult to name.
Much of this literature, however, is more explicit in theorizing the processes through which
Whiteness accrues privilege while disadvantage accumulates among racially labeled groups. For
example, an active body of research explicitly examines the ways that race-based residential segregation
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and urban renewal efforts have served to concentrate poverty and disadvantage in segregated Black or
Latino/a urban communities while concentrating wealth and advantage in segregated White communities,
with subsequent implications for health (Acevedo-Garcia and others, 2003; Fullilove, 2004; Schulz and
others, 2002; Williams and Collins, 2001). This work links processes of racialization and discrimination
to the distribution of resources available to maintain health, probing the ways that Whites accrue
advantage and Blacks, Latinos/as, and other racialized groups accrue systematic disadvantage in terms of
exposures to risks and access to protective factors. Similarly, analyses that probe the intersections of race
and gender and class, including the racialized and gendered nature of the labor market, help to explicate
the reciprocal nature of advantage and disadvantage and their role in producing racial disparities in health
(Mullings and Wali, 2000; Mullings, this volume).
Finally, analyses that turn the lens on the cultural production of difference and differential access
to the means of constructing cultural interpretations (see Geronimus and Thompson, 2005; Weber, this
volume) further interrogate the production of inequalities, including the role of Whiteness in sustaining
systems of racial inequality. Explicit examinations of Whiteness projects can make more visible the
processes through which racial hierarchies are reproduced. Bringing such analyses to research on racial
disparities in health moves us toward what Winant has termed “new abolitionist” Whiteness projects,
those that explicitly focus on deconstructing or decentering White racial privilege by analyzing the
construction of Whiteness. Placing Whiteness under such a critical lens in future studies of racial
disparities in health can contribute to an examination of the complex forms that Whiteness projects take,
ranging from those that reproduce racial hierarchies to those that may disrupt and potentially transform
those hierarchies. Scholars have raised important concerns and caveats about contemporary
investigations of Whiteness (Arnesen, 2001; Fine, 1997; Stein, 2001; Winant, 1997) while encouraging
continued critical attention to the contribution of Whiteness in social, political, and cultural processes that
perpetuate racial inequalities.
In the following section, we examine the emergence of various Whiteness projects within the
context of the Human Genome Project over the past decade or so. Building on our analysis of the
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absence of an explicit theory of race as a set of social relations, we examine how that absence enables the
production of a variety of racial projects that construct Whiteness while enabling it to remain relatively
invisible. This invisibility facilitates Whiteness projects that simultaneously perpetuate inequalities (and
thus disparities in health) while undermining the potential for more transformational Whiteness projects
that could contribute to the disruption of racial hierarchies and the health disparities that they produce.

CONSTRUCTING WHITENESS THROUGH GENETIC EXPLANATIONS FOR RACIAL
DISPARITIES
Writing in 1997, Winant asserted that the neoconservative racial project was “far more
complicated now than ever before, largely due to the present unavailability of biologistic forms of racism
as a convenient rationale for white supremacy” (Winant 1997:45). However, in the first years of the 21st
century, there has been a dramatic resurgence in the availability of biology as an explanation for
persistent racial differences. In fact, the interest among scholars, mainstream media, and the lay public in
biological or genetic explanations for differences between racial groups has been so pronounced that
Barbara Katz Rothman describes this “genetic frame” as a new “way of thinking” (2001:2). While not
the equivalent of the biologistic racism of the far right racial project, the biologically based individualism
of neoconservative Whiteness constructs and reinforces notions of “race’” as fixed, rooted in physical
bodies rather than in social constructs, while it also seeks to abrogate racial disparities in health. The
interplay of assumptions and constructions of race and the inevitably of Whiteness are visible as
discussions of genomic research, particularly aspects of genomic research concerned with racial
disparities, unfold.

Background to Human Genome Research

Genomic research, and in particular the Human Genome Project (HGP), has substantially altered
biomedical and health research in racial disparities, precipitating a move toward analysis of genomic
characteristics of individuals or groups (Duster, 2003a; 2003bHaraway, 1997; Katz Rothman, 1998; 2001;
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Stevens, 2002; 2003). Begun in 1990 and completed in 2003, the Human Genome Project was
conducted by an International Human Genome Research Consortium.ii Alongside this academic
consortium, a number of privately owned biotechnology firms, such as Celera, began attempts to map the
human genome, with an eye toward turning a profit from genetic knowledge, particularly in the field of
health (Malakoff and Service, 2001). The goal of both the privately funded efforts and the academic
Human Genome Project was to “analyze the structure of human DNA and to determine the location of an
estimated 100,000 human genes” (Guyer and Collins, 1993). The completion of the HGP has made it
possible to identify and isolate human genes, particularly those associated with disease (van Ommen,
2002). Completion of the Human Genome Project and mapping of the human genome single-nucleotide
polymorphisms (SNPs) are widely regarded, both by genomic researchers and the lay public, as holding
out great promise for the future of diagnostics, treatment, and prevention of disease (Chice, Cariou, and
Mira, 2002; Wade, 2002b).
Frequently considered the medical equivalent of landing on the moon, the HGP seemed to offer
improved opportunities for early diagnosis and treatment when, in 1994, two leading scientists wrote that
“The ability to predict the development of disease makes possible early intervention to limit the severity
of a disease or to use gene therapy to cure inherited disorders” (Gottesman and Collins, 1994:591).
While some have tempered their enthusiasm in the years since the start of the HGP, neither the unfulfilled
goal of early diagnosis and intervention to limit the severity of disease nor the illusive promise of gene
therapy to cure inherited disorders has deterred ardent proponents of the possibilities of genomic research
for disease diagnosis, prevention, and treatment (Stevens, 2003).
The Human Genome Project, and genomic research more broadly, are having a ripple effect on
public health research agendas having to do with disparities. Evidence of this genomic ripple effect can
be seen in the growing body of literature that addresses the implications of genomic research for health
promotion and disease prevention (Austin, Peyser, and Khoury, 2000; Khoury, Burke, and Thomson,
2000; Beskow and others, 2001; Chadwick, 2004; Gerard, Hayes, and Rothstein, 2002; Wilkinson and
Targonski, 2003). This emerging literature calls for a variety of responses to genomic research by those
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who work in public health, including “how to address barriers to widespread application” (Gerard, Hayes,
and Rothstein, 2002) and “the integration of genomic competencies among public health professionals”
(Beskow and others, 2001). At the same time, a more critical voice has emerged among scholars within
public health, medicine, genetics research, and related disciplines calling for a more equivocal and
nuanced response to the emergent emphasis on genetic solutions to public health concerns (Anderson and
Nickerson, 2005; Bonham, Warshauer-Baker, and Collins, 2005), including a concern about
overemphasizing genetic explanations for public health problems (Kaufman and Hall, 2003; Stevens,
2003). Funded in the United States by the National Institutes of Health (NIH), the HGP had an annual
budget of approximately $350 million, easily making it the largest recipient of NIH funds. Some have
speculated that in the wake of NIH sponsorship of the HGP, it will be increasingly difficult to obtain NIH
funds for public health research that does not address genomes, such as environmental and behavioral
health research (Wilkinson and Targonski, 2003). We contend that this shift toward the genomic has
profound implications for an understanding of racial disparities in health and, in particular, the
reproduction of Whiteness within public health research and practice that seeks to address racial
disparities.

Whiteness and the Human Genome

The director of the National Human Genome Research Institute (NHGRI) at the National Institutes
of Health, Francis Collins, has stated that the HGP “helped to inform us about how remarkably similar all
human beings are—99.9% at the DNA level. Those who wish to draw precise racial boundaries around
certain groups will not be able to use science as a legitimate justification” (Collins and Mansoura,
2001:221). Other scientists working in the area of population genetics often (though not universally) echo
this disavowal of the existence of race: "One important conclusion of human population genetics is that
races do not exist" (Cavalli-Sforza, 1997:52-53). As one researcher has noted, referring to Hernstein and
Murray’s 1994 work, “This is not the sociobiology seen in The Bell Curve, in which genetically based
intelligence differentials are asserted to characterize different races” (Dunklee, 2003:154). Reframed
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within Winant’s typology, this is not the essentialism of the far right Whiteness project. Rather, the HGP
resonates with neoconservative Whiteness projects as it universalizes, emphasizing similarities in human
genetic material across races, while it simultaneously elevates the individual. This is particularly evident
in both the sampling for the HGP and the claims based on those samples.
Rarely mentioned in the literature, and even less often scrutinized, are the samples and the
sampling strategy used in the Human Genome Project and the associated private ventures on which this
claim of “shared humanity” is based. Scientists working on the HGP from both the academic consortium
and the privately funded biotechnology firms originally proposed to include a “diverse” sample of DNA
for mapping the human genome: that is, chromosomal samples taken from people of a variety of racial
and ethnic backgrounds. For example, the website for the academic consortium responsible for the
Human Genome Project in the U.S. indicates that “candidates were recruited from a diverse population”
(http://www.genome.gov/11006943). The private effort to map the human genome, led by the biotech
firm Celera, claimed to be using an even more deliberately “diverse” chromosomal sample. Venter and
others (2001) write, “Celera and the IRB believed that the initial version of a completed human genome
should be a composite derived from multiple donors of diverse ethnic backgrounds” (Venter and others,
2001:1306). DNA samples were collected from 21 volunteer male and female donors who self-identified
their racial/ethnic category (Venter and others, 2001:1306). From those 21 donors, DNA was selected
from five subjects (one African American, one Asian Chinese, one Hispanic Mexican, and two
Caucasians, two of whom were male and three female (Venter and others, 2001:1307). The decision
about whose DNA to sequence was based on “a complex mix of factors, including the goal of achieving
diversity, as well as technical issues such as the quality of the DNA libraries and availability of
immortalized cell lines” (Venter and others, 2001:1307). Thus, both the academic consortium and the
private firm involved in mapping the human genome originally sought to include DNA from people of
diverse racial/ethnic backgrounds as well as gender. Upon completion of 90% of the mapping project,
Collins of the NHGRI and Venter of Celera—former competitors in the race to map the human genome—
held a joint press conference with President Clinton to announce the completion of a “rough draft of the
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human genome” (Wade, 2000), ostensibly on this diverse sample of DNA.
However, both the academic HGP and the privately funded mapping project have been criticized
for not selecting a sample that is diverse enough to serve as the map of the human genome (Jackson,
1997). In point of fact, the chromosomal reference samples for the academic HGP were taken from
“sixty-seven northern American and northern European men” with a large portion oversampled from Utah
(Stevens, 2002:110). As for the private venture at Celera, after the project was completed, Celera’s CEO
Craig Venter revealed the mapping that his firm had done had not been on the “diverse” chromosomal
sample of donated DNA but rather on his (Venter’s) own DNA (Wade, 2002a). Explaining the use of his
own DNA, Venter cited both “privacy concerns” for volunteers who submitted DNA to the project and
his curiosity about the uniqueness of his own DNA (Wade, 2002a).iii The point of noting this
discrepancy here between the claim of shared genetic universality and the limited sampling diversity (to
vastly understate the case) of DNA actually used for mapping the human genome is to raise one of the
central dilemmas for those interested in critically engaging the genomic literature and the construction of
Whiteness. On the one hand, charging that the DNA sample was not “diverse enough” across racial and
ethnic groups presumes that there are significant genetic racial differences between groups that should be
studied. Indeed, Fatimah Jackson argues forcefully against the applicability of the heavily North
American and northern European sample of the HGP to people who are descendants of African ancestors
(1997). She calls for separate genetic studies of Africans directed by Africans and African Americans
(Jackson, 1997).iv But this critique of the limited genome sample, while powerful, does little to upend the
reliance on biologically based notions of racial taxonomies. More to the point for our discussion here,
this type of argument leaves the normativity of Whiteness unexamined by calling for further mapping of
ostensibly genetically distinct racial groupings rather than interrogating the notion that Whiteness is a
homogenous and genetically discreet category. On the other hand, accepting the use of a limited, and
predominantly Caucasian, DNA sample as “the map” of “all humankind” morphs Whiteness into that
which is universally human (Duster, 2001). Returning again to Winant’s typology, neoconservative
Whiteness combines a dual assertion of the universal alongside the assertion of the uniqueness of the
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individual. That Venter in his private venture used only his (Caucasian, male) DNA for mapping (Wade,
2002a) passed with little comment because of the assumption of universality of this genetic sample: any
(White) North American or northern European man is just as human as the next. As it plays out in the
Human Genome Project, the universal “shared inheritance of all humankind” is invoked by leaders of one
faction of the HGP researchers, while another researcher asserts his individual curiosity about his own
DNA. In a very real sense, then, the mapping of the human genome is both a universal appeal to
“humankind” and is based on the DNA of a putatively White genome. Yet this is rarely explicitly stated
or called into question. Given the pervasiveness of Whiteness as a racialized norm in the U.S., it is not
surprising that a map constructed from the DNA of northern Europeans and Americans is assumed to
represent “the human” genome (Cross, 2001:435).
Alongside and following shortly after the Human Genome Project began, genetic researchers, led
by Luigi Luca Cavalli-Sforza of Stanford University, proposed the Human Genome Diversity Project
(HGDP) in 1991. Its explicit purpose was to map the diversity of the 0.1% of variation in human
genomes by extracting genetic samples from a variety of geographically distinct populations, with a
particular focus on indigenous peoples around the world. These DNA samples were to be multiplied and
stored for future research. The Human Genome Diversity Project, unlike the Human Genome Project, has
met with strenuous criticism (Dodson and Williamson, 1999; Greely, 2001; Katz Rothman, 2001;
Reardon, 2001; Resnik, 1999). Although the project languished without funding for a number of years,
due in no small measure to opposition by indigenous people (Cross, 2001; Greely, 2001), it has recently
been given new life in a formal working relationship with the HGP (Stevens, 2002:110). The goal of
mapping genetic “diversity” is doubly ironic, given both the minute proportion of variation (0.1%) and
Sforza’s statement quoted above that “races do not exist” (Cavalli-Sforza, 1997). As Jacqueline Stevens
notes, Cavalli-Sforza’s statement that races do not exist is “overshadowed” by the HGDP, “for if they do
not exist, then it makes no sense to study the small differences among them” (Stevens, 2002:109). What
is left unquestioned and unexamined here is the Whiteness of the baseline of comparison. The variation
of 0.1% is variation from some norm, and given the predominance of Caucasians in the sample
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establishing that norm, it is a putatively White genomic standard; mapping the variation from that norm is
a project inherently concerned with mapping difference from Whiteness.
Undaunted by the criticisms and initial failure of the HGDP, another group of genetic researchers
has proposed the “HapMap” project (Couzin, 2002; Gottleib, 2002). One of the discoveries of the Human
Genome Project was that many genes, rather than being transmitted to new generations at random, are
passed down in blocks known as haplotypes (Gabriel and others, 2002). These haplotypes remain largely
unchanged through generations; therefore, genome researchers hypothesize that there may be only a
handful of variations across the entire human population. Further, some genetic researchers speculate that
these small variations may play an important role in the development of diseases such as asthma, cancer,
and diabetes (Collins, 1999). Several countries involved in the HGP have already signed on to the
HapMap project, and $100 million in funding will be shared by researchers in the U.S., Canada, Britain,
China, and Japan (Couzin, 2002; Gottleib, 2002). The research aim is to decode the genetic sources of
disease by comparing the genomes of people in four ethnic groups: Japanese, Han Chinese, the Yoruba
people of Nigeria, and Americans of northern and western European descent (Couzin, 2002).v Clearly,
the HapMap (like the HGDP) project holds the potential for naturalizing racial categories and challenging
claims about the social construction of race by asserting a biological essence of race (Dunklee, 2003;
Duster, 2003a; Katz Rothman, 2001; Stevens, 2002; 2003).
The HapMap’s quest to find genetic markers for fundamentally social racial and ethnic groups,
like the goal of the Human Genome Diversity Project, is a move away from the ostensibly universal
notions of the Human Genome Project. Indeed, Charles Murray (coauthor of The Bell Curve) has been
quoted as saying: “As the HapMap project gets underway, this would seem to be a good time to put bets
on the table regarding how the results will affect the ongoing debate about whether race is a valid and/or
useful construct… the HapMap results will move the current consensus toward the traditional end. Race
will regain credibility as a useful, albeit imprecise, way to categorize human beings.” (Quoted in Cohen
and others, 2003)
Here, the promise of genomic research in any sense of the universal (“we are all one,” “99.9%
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the same DNA”) has disappeared. In its place is a move toward reconstructing “race”—and thus,
inevitably Whiteness—in a manner that reproduces racial difference as immutable genetic difference.
Many genomic researchers share an assumption that the goal of genetic research is to identify
those specific genes and gene variants that influence the diagnosis, prevention, and treatment of disease,
with little or no emphasis on race at a genomic level (Collins and others, 2003). However, a subset of
researchers continues to use self-identified and inherently social racial categorizations as a means to
identify populations for genetic study, arguing that it is more economical to categorize people based on
phenotypically based notions of “race” rather than to look exclusively at individual genetic composition
for prevention, diagnosis, and treatment of disease (Risch and others, 2002). Risch and colleagues argue
that “population genetic studies have recapitulated the classical definition of races based on continental
ancestry—namely African, Caucasian (Europe and Middle East), Asian, Pacific Islander (for example,
Australian, New Guinean, and Melanesian), and Native American” (Risch and others, 2002:3). The
continued use of “race” as a heuristic device for investigation at the genomic level is paradoxical, when
on its face individualized genetic therapy would mean testing and categorization on the individual level.
This return to the use of classical racial categories in population genetics studies despite empirical
evidence documenting the clear limits of these categories as indicative of ancestry or heritage (such as the
U.S. census and birth record examples described earlier in this chapter) highlights the power of these
socially constructed categories within science, as well as the role of scientific research in continuing to
reproduce these categories.
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Figure 1: The evolutionary tree of human races. Population genetic studies of world populations
support the categorization into five major groups, as shown. From Risch and others, 2002, fig. 1
This is a particularly pernicious use of racial categories. While the evidence from genetic research
confirms the similarities of human beings across racial categories, geneticists like Risch want to continue
to use social categories as a “practical” matter to underwrite the enormous costs of authentically
individualized genetic testing and screening.
As Bonham and colleagues point out, attributing racial variations in patterns of disease to the
genetic composition of racial or ethnic groups is based on a series of imperfect assumptions. Specifically,
"self-identified race is a surrogate for ancestral geographic origin, which is a surrogate for variation
across the genome, which is a surrogate for variation in disease-relevant alleles, which is a surrogate for
individual disease risk" (Bonham, Warshauer-Baker, and Collins, 2005:13, citing Collins, 2004). With
each imperfect assumption, the link between socially constructed racial categories and genetic sources of
disease gets less clear, like a copy of a copy of a copy that continues to blur with each reproduction; yet
the genetic frame, and the supposedly biological basis for Whiteness, remains unchallenged. This
reliance on race as a sorting mechanism of convenience in the face of genomic research that demonstrates
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this is a less than completely reliable proxy simultaneously naturalizes racial disparities while it holds out
the promise of eliminating racial disparities in health. And it leaves the Whiteness within those disparities
unexamined.
Furthermore, scholars have also pointed out the impulse to attach genetic conditions to labeled
racial or ethnic groups, while those attached to “Whites” remain invisible. For example, genetically
linked conditions such as Tay-Sachs or sickle cell anemia have become labeled as “Jewish” and “Black”
diseases respectively because they are associated with people who are descendants of Ashkenazi Jews and
African Americans. However, a disease such as cystic fibrosis, which is genetically linked to subgroups
of the White population, does not get labeled as difference (Katz Rothman, 1998). The link, then,
between genetic condition and Whiteness is ephemeral, while the connection between genetic condition
and members of (already) labeled racial and ethnic groups is intractable. Schwalbe and colleagues have
pointed to the process of identifying and labeling groups as crucial to the process of reproducing
inequalities (Schwalbe and others, 2000). Thus, the HapMap’s explicit quest to locate difference at the
genetic level contributes to a Whiteness project that both reifies racial categories and contributes to the
identification of disease risk as located within racialized groups.
Returning again to Winant’s typology of different Whiteness projects, the “classical” definition of
races mentioned here seems to move away from the neoconservative Whiteness project and toward the far
right Whiteness project of biological essentialism. Indeed, Risch’s “evolutionary tree of human races” is
actually quite close to de Gobineau’s conceptualization in Inequality of the Races (1853), an essay widely
regarded as crucial in the development of contemporary Western “racist culture” (Goldberg, 1993). Here
we have moved fully from the neoconservative racial project on to the far right racial project in which
race is seen as biologically based and Whiteness morphs (Duster, 2001) into a discrete line, distinct from
others and solidified. Thus, the explicit quest to locate difference at the genetic level contributes to a
Whiteness project that reifies racial categories and return to pre-Civil Rights Movement constructions of
race and Whiteness as inherent, biological difference.
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WHITENESS IN HEALTH DISPARITIES RESEARCH

Scholars both within and outside the field of public health have drawn attention to the limits of
analyses and interventions that focus on biological or behavioral explanations for health and disease,
without understanding the social contexts within which health and disease are produced (Geronimus,
2000; House and others, 1994; House and Williams, 2000; Link and Phelan, 1995; Lupton, 1995; Schulz
and others, 2002; Williams and Collins, 2001). Specifically, they have argued that such a focus serves to
locate the causes of poor health within the bodies of those individuals or groups who are most visibly
affected by social, economic, and political powerlessness while drawing attention away from the broader
social processes that influence opportunities for health as well as risk of disease (Lupton, 1995; Muntaner,
1999; Shah, 2001).
In this chapter, we have examined one aspect of this process —the ways that race and Whiteness
are constructed in the literature on racial disparities in health and the ways that this literature may
contribute to the reification or reproduction of the racial categories that are fundamental to the production
of racial inequalities (Schwalbe and others, 2000). We suggest that this challenge resurfaces particularly
in the absence of a specifically social theory of race, and of whiteness. Following Muntaner (1999), we
argue that the absence of an explicitly social theory of race allows a wide range of interpretations of racial
disparities in health to emerge, implicitly or explicitly locating the causes of health and disease within
individuals, particular groups (e.g., Mexicans, Chinese Americans, the poor), or social relations (e.g.,
hierarchies of race and class).
These interpretations, each of which can be linked to various Whiteness or, more broadly, racial,
projects, do not occur in isolation from the larger social and political context. Over the past several
decades in the United States, neoliberal and neoconservative Whiteness projects have been in constant
flux. Recently, as the mainstream of U.S. politics has moved rightward, challenges have emerged to
social and behavioral epidemiological research on health disparities (Zielhuis and Kiemeny, 2001), while
biomedical and genomic research on racial disparities in health have reemerged.
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Nelkin and Lindee suggested a decade ago that the power of genetic explanations for racial
disparities in health may derive in part from the exoneration of the individual, “removing moral
responsibility by providing a biological ‘excuse.’ Genes are the agents of destiny: We are the victims of a
molecule, captives of our heredity” (1995:129). Yet, as Kaufman and Hall point out more recently, “The
myth of genetic determinism cuts both ways, however, for although it absolves the individual from
responsibility, it also absolves the society at large. Deterministic biological explanations (‘it’s in my
genes’)—much like theological explanations (‘the devil made me do it’)—locate problems (and therefore
solutions) within individuals” (2003:117). Genetic explanations for racial disparities in health ignore the
historically situated and contextual nature of processes of racialization, shifting the lens away from the
ways that those processes are linked to the social, political, and economic conditions that influence health.
Instead, by locating the cause of health disparities within the genes—or haplotypes—of racialized groups,
they suggest that there is “something innately pathologic” about that group, reinforcing their “essential
physical inferiority in the modern world.” (2003:117). Such interpretations obscure the social processes
that create inequality, contribute to the stigmatization of racialized groups (and thus perpetuate
inequalities), and allow Whiteness to remain invisible and uninterrogated.
While we have focused particular attention on genetic research in the latter half of this chapter,
this same process may play out with any research that does not put forward a specifically social theory of
race. For example, research into the extent to which behaviors or cultural practices contribute to racial
disparities in health, without explicit theoretical linkages to social and historical contexts, can reproduce
ideas of immutable difference between racial groups. To the extent that culture, for example, comes to be
perceived as an innate characteristic distinct to particular racial or ethnic groups, it “inherits the role of
race…[and] becomes determinist and teleological,” reproducing the idea of inherent differences between
groups (Malik, 1996:150).
Explicitly theorizing race as a social construct encourages us to examine how processes of
racialization are linked to social, political, and economic conditions that, in turn, influence health
outcomes. By moving beyond the use of race as an atheoretical and ahistorical category and toward
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analysis of the processes through which racial constructs are produced and linked to differences in health,
researchers can contribute to etiologic research that identifies the underlying—or fundamental—causes of
racial disparities in health. This includes an understanding of the ways that race is implicated in the
construction of class, as well as the ways that class is implicated in the construction of race (Buck, 2001).
Even more so, it is imperative for those vested in understanding and addressing health
disparities—whether population geneticists, social epidemiologists, or public health practitioners—to
examine critically the assumptions and implicit as well as explicit theoretical frameworks that we bring to
our work. Only in so doing can we begin to understand the ways that socially constructed racial
categories permeate our own implicit assumptions and interpretations, as well as the ways that research on
racial disparities in health may, advertently or inadvertently, reproduce the racial categories that are
themselves fundamental to the processes of inequality. Scholars who make explicit connections between
social conditions and the historical and locally contingent production of Whiteness and its connections to
relative advantage in the distribution of material, political, and cultural resources begin to disrupt the
invisibility of Whiteness and offer the potential for transformational racial projects to emerge.
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NOTES
PubMed search conducted February 2005 using search terms “racial disparities.”
The International Human Genome Sequencing Consortium includes:
1. The Whitehead Institute/MIT Center for Genome Research, Cambridge, Mass., U.S.
2. The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton,
i
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Cambridgeshire, U.K.
3. Washington University School of Medicine Genome Sequencing Center, St. Louis, Mo., U.S.
4. United States DOE Joint Genome Institute, Walnut Creek, Calif., U.S.
5. Baylor College of Medicine Human Genome Sequencing Center, Department of Molecular and Human
Genetics, Houston, Tex., U.S.
6. RIKEN Genomic Sciences Center, Yokohama, Japan
7. Genoscope and CNRS UMR-8030, Evry, France
8. GTC Sequencing Center, Genome Therapeutics Corporation, Waltham, Mass., U.S.
9. Department of Genome Analysis, Institute of Molecular Biotechnology, Jena, Germany
10. Beijing Genomics Institute/Human Genome Center, Institute of Genetics, Chinese Academy of
Sciences, Beijing, China
11. Multimegabase Sequencing Center, The Institute for Systems Biology, Seattle, Wash.
12. Stanford Genome Technology Center, Stanford, Calif., U.S.
13. Stanford Human Genome Center and Department of Genetics, Stanford University School of
Medicine, Stanford, Calif., U.S.
14. University of Washington Genome Center, Seattle, Wash., U.S.
15. Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan
16. University of Texas Southwestern Medical Center at Dallas, Dallas, Tex., U.S.
17. University of Oklahoma's Advanced Center for Genome Technology, Dept. of Chemistry and
Biochemistry, University of Oklahoma, Norman, Okla., U.S.
18. Max Planck Institute for Molecular Genetics, Berlin, Germany
19. Cold Spring Harbor Laboratory, Lita Annenberg Hazen Genome Center, Cold Spring Harbor, N.Y.,
U.S.
20. GBF - German Research Centre for Biotechnology, Braunschweig, Germany
iii

Since he had his DNA sequenced, Venter has been following an individually tailored regime for a
condition that is known to be a precursor to Alzheimer’s (Wade, 2002a). Most of the genetic research
community involved in mapping the human genome found Venter’s announcement less than noteworthy.
Collins of the NHGRI, who shared the joint press conference with Venter, declined to comment on the
revelation (Wade, 2002a).
iv

And, indeed, a project known as G-RAP, Genomic Research in African-American Pedigree, is under
way at Howard University, based precisely on the notion of understanding "gene-based differences."
v
According to a News Advisory titled “Background on Ethical and Sampling Issues Raised by the
International HapMap Project,” the NHGRI’s website describes the rationale for selecting these groups in
these terms: “These four populations were selected to include people with ancestry from widely separate
geographic regions. Researchers have found that most human populations share the common haplotype
patterns. Research already suggests that the overall organization of genetic variation is similar in all four
populations, but that there will be enough differences in haplotype frequencies to justify genome-wide
studies of samples from these populations.” [http://genome.gov/10005337 ]. Accessed March 28, 2005.
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